DK2330188T3 - Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP) - Google Patents

Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP) Download PDF

Info

Publication number: DK2330188T3
Authority: DK; Denmark
Prior art keywords: nucleotide sequence; polypeptide; sequence; nucleotide; map
Prior art date: 1997-12-05

Application number

DK10184626.9T

Other languages

English (en)

Inventor

André Jestin

Emmanuel Albina

Cann Pierre Le

Philippe Blanchard

Evelyne Hutet

Claire Arnaud

Catherine Truong

Dominique Mahe

Roland Cariolet

François Madec

Original Assignee

Zoetis Services Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-05

Filing date

1998-12-04

Publication date

2015-10-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2330188(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-12-04 Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc

2015-10-19 Application granted granted Critical

2015-10-19 Publication of DK2330188T3 publication Critical patent/DK2330188T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)

DK10184626.9T 1997-12-05 1998-12-04 Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP) DK2330188T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9715396A FR2772047B1 (fr)	1997-12-05	1997-12-05	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP08154913.1A EP1992696B1 (fr)	1997-12-05	1998-12-04	Séquences de circovirus associé à la maladie de l'amaigrissement du porcelet (MAP)

Publications (1)

Publication Number	Publication Date
DK2330188T3 true DK2330188T3 (da)	2015-10-19

Family

ID=9514225

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
DK08154913.1T DK1992696T3 (da)	1997-12-05	1998-12-04	Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD).
DK08154912.3T DK2000535T3 (da)	1997-12-05	1998-12-04	Sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD).
DK98958957.7T DK1036180T4 (da)	1997-12-05	1998-12-04	Vaccine på grundlag af sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD)
DK10184626.9T DK2330188T3 (da)	1997-12-05	1998-12-04	Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)
DK10184556.8T DK2316925T3 (da)	1997-12-05	1998-12-04	Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
DK08154913.1T DK1992696T3 (da)	1997-12-05	1998-12-04	Circovirussekvenser forbundet med udmagringssygdom hos pattegrise (PWD).
DK08154912.3T DK2000535T3 (da)	1997-12-05	1998-12-04	Sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD).
DK98958957.7T DK1036180T4 (da)	1997-12-05	1998-12-04	Vaccine på grundlag af sekvenser af circovirus type B forbundet med udmagringssygdom hos pattegrise (PWD)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK10184556.8T DK2316925T3 (da)	1997-12-05	1998-12-04	Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)

Country Status (15)

Country	Link
US (43)	US6703023B1 (da)
EP (6)	EP1992696B1 (da)
AT (1)	ATE412664T1 (da)
AU (1)	AU1491699A (da)
BE (2)	BE2014C050I2 (da)
CY (6)	CY1115405T1 (da)
DE (1)	DE69840174D1 (da)
DK (5)	DK1992696T3 (da)
ES (5)	ES2548146T3 (da)
FR (3)	FR2772047B1 (da)
HK (1)	HK1222415A1 (da)
LU (2)	LU92523I2 (da)
NL (2)	NL300685I2 (da)
PT (5)	PT2316925E (da)
WO (1)	WO1999029871A2 (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
US7211379B2 (en)	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
AU2002302120B2 (en) *	1997-10-03	2006-01-19	Merial	Porcine circoviruses, vaccines and diagnostic reagents
US7192594B2 (en)	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
AU2003248395B2 (en) *	1997-10-03	2006-03-16	Merial	Porcine CircoViruses, vaccines and diagnostic reagents
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
EP1816200B1 (en) *	1997-12-11	2016-03-09	Merial	Postweaning multisystemic wasting syndrome virus for pigs
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) *	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
ES2170622B1 (es) *	1999-12-03	2004-05-16	Consejo Superior De Investigaciones Cientificas	Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
AU2001238535A1 (en)	2000-02-16	2001-08-27	Large Scale Biology Corporation	Rolling circle replicon expression vectors
CA2442135C (en)	2001-03-27	2008-08-19	University Of Saskatchewan	Methods to culture circovirus
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SI1833992T1 (sl)	2004-12-30	2015-06-30	Boehringer Ingelheim Vetmedica, Inc.	PCV2 imunogeni sestavki in postopki proizvodnje takĹˇnih sestavkov
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
AU2011253941B2 (en) *	2004-12-30	2015-01-29	Boehringer Ingelheim Animal Health USA Inc.	PCV2 immunogenic compositions and methods of producing such compositions
ITBO20050123A1 (it)	2005-03-07	2005-06-06	Alfa Wassermann Spa	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
WO2006132598A1 (en) *	2005-06-07	2006-12-14	Temasek Life Sciences Laboratory Limited	Porcine circovirus type 2 vaccines
DK1926496T3 (da) *	2005-09-09	2013-09-30	Intervet Int Bv	PCV-2-vaccine
EP3320919B1 (en) *	2005-12-29	2020-05-27	Boehringer Ingelheim Animal Health USA Inc.	Multivalent pcv2 immunogenic compositions and methods of producing such compositions
DK2371383T3 (da)	2005-12-29	2015-11-30	Boehringer Ingelheim Vetmed	Anvendelse af en PCV2-immunogen sammensætning til mindskning af kliniske symptomer i grise
US20100136060A1 (en) *	2006-11-22	2010-06-03	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
AU2007333857B2 (en) *	2006-12-15	2014-05-15	Boehringer Ingelheim Animal Health USA Inc.	Treatment of pigs with PCV2 antigen
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
AU2007353480B2 (en) *	2007-05-11	2013-09-19	Temasek Life Sciences Laboratory Limited	Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
US20090162398A1 (en) *	2007-12-21	2009-06-25	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US20110020394A1 (en) *	2007-12-31	2011-01-27	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 orf2 virus like particle with foreign amino acid insertion
CA2712006A1 (en) *	2008-01-23	2009-10-15	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
WO2009103037A1 (en) *	2008-02-15	2009-08-20	Boehringer Ingelheim Vetmedica, Inc.	Methods and compositions for reducing the impact of enteric diseases
EP2356132A2 (en) *	2008-10-16	2011-08-17	Pfizer Inc.	Torque teno virus (ttv) isolates and compositions
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
WO2011041796A1 (en)	2009-10-02	2011-04-07	Pioneer Hi-Bred International, Inc.	Down-regulation of acc synthase for improved plant performance
US8846388B2 (en)	2009-10-16	2014-09-30	Zoetis Llc	Infectious clones of torque teno virus
JP2013507918A (ja) *	2009-10-16	2013-03-07	ファイザー・インク	トルクテノウイルスの感染性クローン
CN102711816A (zh) *	2009-10-22	2012-10-03	莱比锡大学	患有牛新生儿全血细胞减少症的小牛中的圆环病毒的检测
EP2528931A4 (en) *	2010-01-25	2013-12-04	Blood Systems Inc	CYCLOVIRUS AND USE METHOD THEREFOR
KR20110090711A (ko) *	2010-02-04	2011-08-10	녹십자수의약품(주)	신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI508974B (zh)	2010-12-22	2015-11-21	Sbc Virbac Ltd	豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
US9677084B2 (en)	2011-04-29	2017-06-13	Pioneer Hi-Bred International, Inc.	Down-regulation of a homeodomain-leucine zipper I-class homeobox gene for improved plant performance
HUP1100470A2 (en)	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
EP2564869A1 (en)	2011-09-02	2013-03-06	Ceva Sante Animale	Synthetic capsid proteins and uses thereof
UA113192C2 (xx)	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
EP3587439A3 (en)	2013-03-01	2020-03-11	Boehringer Ingelheim Animal Health USA Inc.	Improved quantification of vaccine compositions
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
EP2789346A1 (en)	2013-04-11	2014-10-15	CEVA Santé Animale SA	Fusion polypeptides and vaccines
DK2994162T3 (en)	2013-05-08	2021-06-21	Pharmgate Biologics Inc	Vaccine for pcv2 og mycoplasma
RU2662685C2 (ru)	2013-09-25	2018-07-26	Зоэтис Сервисиз Ллс	Pcv2b дивергентная вакцинная композиция и способы её применения
KR20220083861A (ko)	2013-10-02	2022-06-20	베링거 인겔하임 애니멀 헬스 유에스에이 인크.	Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
EP3034609A1 (en)	2014-12-19	2016-06-22	Ceva Sante Animale	Recombinant swinepox virus and vaccines
EP3254692A1 (en)	2016-06-10	2017-12-13	Ceva Sante Animale	Multivalent recombinant spv
WO2019032830A1 (en)	2017-08-09	2019-02-14	Dreamwell, Ltd.	ADJUSTABLE SUPPORT STRUCTURE
US20200390878A1 (en)	2017-12-08	2020-12-17	Ceva Sante Animale	Recombinant swinepox virus and vaccines
CN112088013B (zh)	2018-03-26	2024-12-06	勃林格殷格翰动物保健美国有限公司	制备免疫原性组合物的方法
JP2021527073A (ja)	2018-06-11	2021-10-11	セヴァサンテアニマレＣｅｖａＳａｎｔｅＡｎｉｍａｌｅ	ブタサーコウイルスに対するワクチン接種
AU2021358061A1 (en) *	2020-10-06	2023-06-08	Materials and Machines Corporation of America	Method for detection of rna or dna from biological samples
WO2023192936A2 (en) *	2022-03-30	2023-10-05	Fred Hutchinson Cancer Center	Systems and methods to produce b cells that express selected antibodies and gene products
CN114736310B (zh) *	2022-06-10	2022-10-28	北京华夏兴洋生物科技有限公司	产生圆环病毒2型病毒样颗粒的蛋白质及生物材料与应用
TW202508619A (zh)	2023-05-03	2025-03-01	德商百靈佳殷格翰維美迪加股份有限公司	用於誘導免疫反應之方法
AR132581A1 (es)	2023-05-03	2025-07-16	Boehringer Ingelheim Vetmedica Gmbh	Composición inmunógena útil para la autoadministración por cerdos

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US69750A (en) *		1867-10-15		Henry bean
US69233A (en) *		1867-09-24		Joseph r
FR2422956A1 (fr)	1978-04-13	1979-11-09	Pasteur Institut	Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
FR2464269B1 (fr)	1979-08-30	1986-04-18	Anvar	Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr)	1981-12-23	1986-04-11	Pasteur Institut	Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
US5833975A (en)	1989-03-08	1998-11-10	Virogenetics Corporation	Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en) *	1983-05-27	1988-05-17	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector
US4946787A (en)	1985-01-07	1990-08-07	Syntex (U.S.A.) Inc.	N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5545412A (en)	1985-01-07	1996-08-13	Syntex (U.S.A.) Inc.	N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US5106733A (en)	1987-06-25	1992-04-21	Immunex Corporation	Bovine granulocyte-macrophage colony stimulating factor
SU1538305A1 (ru)	1987-07-21	1994-12-15	Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР	Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5069901A (en)	1988-02-03	1991-12-03	Jones Elaine V	Preparation of a recombinant subunit vaccine against pseudorabies infection
DE69027112T2 (de)	1989-01-23	1997-01-09	Auspharm International Ltd 4Th	Impfstoffzusammensetzung
US5811103A (en)	1989-03-19	1998-09-22	Akzo Nobel N.V.	Hog cholera virus vaccine and diagnostic
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
DE69034168T3 (de)	1989-03-21	2013-04-11	Vical, Inc.	Expression von exogenen Polynukleotidsequenzen in Wirbeltieren
US5800992A (en) *	1989-06-07	1998-09-01	Fodor; Stephen P.A.	Method of detecting nucleic acids
US5264618A (en)	1990-04-19	1993-11-23	Vical, Inc.	Cationic lipids for intracellular delivery of biologically active molecules
AU657907B2 (en)	1990-05-29	1995-03-30	Wyeth Holdings Corporation	Mycoplasma hyopneumoniae vaccine
US5565205A (en)	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
WO1992005255A1 (en)	1990-09-13	1992-04-02	Commonwealth Scientific And Industrial Research Organisation	Ovine cytokine genes
GB9023111D0 (en) *	1990-10-24	1990-12-05	Wellcome Found	Expression system
EP0555366B1 (en)	1990-11-01	2000-06-28	Iowa State University Research Foundation, Inc.	Bacterial attenuation method and vaccine
AU672359B2 (en)	1991-03-07	1996-10-03	Virogenetics Corporation	Genetically engineered vaccine strain
ES2026827A6 (es)	1991-03-26	1992-05-01	Ercros Sa	Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
US5580557A (en)	1991-10-09	1996-12-03	Iowa State University Research Foundation, Inc.	Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US5382425A (en)	1992-01-13	1995-01-17	Syntro Corporation	Recombinant swinepox virus
US6033904A (en)	1992-01-13	2000-03-07	Syntro Corporation	Recombinant swinepox virus
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
CA2139756A1 (en)	1992-07-08	1994-01-20	Eric M. Bonnem	Use of gm-csf as a vaccine adjuvant
JP3149116B2 (ja) *	1992-10-28	2001-03-26	信越化学工業株式会社	ヒトパルボウイルスのエピトープ関連ペプチド
AU675269B2 (en) *	1992-11-09	1997-01-30	Zonagen, Inc.	Materials and methods for immunocontraception
CZ289743B6 (cs)	1993-02-08	2002-03-13	Bayer Corporation	Izolát viru vepřového reprodukčního a respiračního syndromu PRRSV, způsob kultivace PRRSV, tkáňová kultura, způsob přípravy vakcíny a vakcína obsahující PRRSV izolát
EP0620277A1 (en)	1993-03-18	1994-10-19	Merck & Co. Inc.	Nucleic acid pharmaceuticals
EP0698245A1 (en)	1993-05-14	1996-02-28	Mds Health Group Limited	Electronic worksheet system for microbiology testing and reporting
EP0702516A4 (en)	1993-06-01	1998-04-22	Life Technologies Inc	GENETIC IMMUNIZATION WITH CATIONIC LIPIDS
JP3626187B2 (ja)	1993-06-07	2005-03-02	バイカルインコーポレイテッド	遺伝子治療に適するプラスミド
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
GB2285766B (en)	1994-01-21	1997-07-23	Ecc Int Ltd	Ceramic casting composition
KR0121105B1 (ko) *	1994-02-04	1997-11-10	문정환	선입선출메모리 버스장치
WO1995024929A2 (en)	1994-03-15	1995-09-21	Brown University Research Foundation	Polymeric gene delivery system
EP0758397B1 (en)	1994-04-29	2005-06-22	Baxter Healthcare S.A.	Recombinant poxviruses with foreign polynucleotides in essential regions
SI0968722T1 (sl)	1994-05-10	2007-10-31	Wyeth Corp	Izboljĺ ano, modificirano ĺ˝ivo cepivo proti brsv
GB2289279B (en)	1994-05-13	1998-09-16	Iberica Cyanamid	Diagnostic kits and vaccines containing recombinant PRRSV proteins
US5719131A (en)	1994-12-09	1998-02-17	Genzyme Corporation	Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5840306A (en) *	1995-03-22	1998-11-24	Merck & Co., Inc.	DNA encoding human papillomavirus type 18
US6043232A (en)	1997-07-23	2000-03-28	Nitromed, Inc.	Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
EP0826063A1 (en)	1995-04-25	1998-03-04	Vical Incorporated	Single-vial formulations of dna/lipid complexes
US5681658A (en) *	1995-05-30	1997-10-28	Aluminum Company Of America	Gelation-resistant alumina
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5705385A (en)	1995-06-07	1998-01-06	Inex Pharmaceuticals Corporation	Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5820869A (en)	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
CN1194001A (zh)	1995-06-07	1998-09-23	埃斯库拉普公司	鸡贫血症病毒的中和构象表位
US6019980A (en)	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US5795872A (en)	1995-09-19	1998-08-18	Pharmadigm, Inc.	DNA construct for immunization
FR2751224B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
PT835930E (pt)	1996-10-09	2001-06-29	Akzo Nobel Nv	Estirpes europeias de vacina do virus do sindroma reprodutivo e respiratorio porcino (prrsv)
AU1987197A (en)	1997-03-10	1998-09-29	Heather Lynn Davis	Gene delivery to mucosal epithelium for immunization or therapeutic purpose
US5990091A (en)	1997-03-12	1999-11-23	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US6004777A (en)	1997-03-12	1999-12-21	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US20030215445A1 (en) *	1997-05-23	2003-11-20	Ginette Serrero	Methods and compositions for inhibiting the growth of hematopoietic malignant cells
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6143334A (en) *	1997-10-03	2000-11-07	Sargento Foods Inc.	Pasta filata method for manufacturing Swiss-type cheeses
US7192594B2 (en) *	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2781159B1 (fr)	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
US6391314B1 (en) *	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
US7211379B2 (en) *	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US6165493A (en)	1997-10-22	2000-12-26	New York Blood Center, Inc.	"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20040062775A1 (en)	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) *	1998-03-13	1999-09-16	University Of Georgia Research Foundation, Inc.	Vaccines against circovirus infections
US6294176B1 (en) *	1998-07-10	2001-09-25	Schering-Plough Veterinary Corp.	Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
WO2000024428A2 (en)	1998-10-23	2000-05-04	Heska Corporation	Cationic lipid-mediated enhancement of nucleic acid immunization of cats
US6143333A (en)	1998-11-13	2000-11-07	Purina Mills, Inc.	Method of preparing a packaged fish attractant block
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6497883B1 (en)	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6139179A (en)	1999-09-03	2000-10-31	Davis-Standard Corporation	Extruder screw having multi-channeled barrier section
US6179461B1 (en)	1999-09-03	2001-01-30	Davis-Standard Corporation	Extruder screw
GB9921147D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
GB9921146D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
WO2001017556A1 (fr)	1999-09-07	2001-03-15	Shionogi & Co., Ltd.	Préparations vaccinales administrables par les muqueuses
WO2001034609A1 (de) *	1999-11-10	2001-05-17	Optische Werke G. Rodenstock	Heterocyclisch annellierte indenochromenderivate
US6366601B1 (en) *	1999-11-17	2002-04-02	Motorola, Inc.	Variable rate spread spectrum communication method and apparatus
US7233407B1 (en) *	2000-02-02	2007-06-19	Xerox Corporation	Document production system for capturing web page content
JP3363419B2 (ja) *	1999-12-24	2003-01-08	住友ゴム工業株式会社	重荷重用ラジアルタイヤ
CA2410229A1 (en)	2000-06-15	2001-12-20	Purdue Research Foundation	Vaccine for congenital tremors in pigs
JP4768106B2 (ja)	2000-07-31	2011-09-07	スリーエムイノベイティブプロパティズカンパニー	接着剤組成物及び熱剥離容易な接着構造
DE10044646A1 (de)	2000-09-08	2002-04-04	Horsch Maschinen Gmbh	Spritzgestängeführung
DE10044648A1 (de)	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
DE10051562A1 (de) *	2000-10-18	2002-04-25	Emitec Emissionstechnologie	Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen
US6572081B2 (en) *	2000-12-27	2003-06-03	Nkf Kabel B.V.	Installation of guide tubes in a protective duct
CA2442135C (en) *	2001-03-27	2008-08-19	University Of Saskatchewan	Methods to culture circovirus
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines
US7279166B2 (en) *	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en)	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US20030215455A1 (en) *	2002-05-14	2003-11-20	Bailey Reynolds	Vaccine stabilizer and method of use
CA2507520C (en) *	2002-11-28	2007-01-23	Research In Motion Limited	Multiple-band antenna with patch and slot structures
US7288529B2 (en) *	2003-04-24	2007-10-30	New York University	ALK protein tyrosine kinase, cells and methods embodying and using same
UA87665C2 (ru)	2003-07-25	2009-08-10	Берингер Ингельхайм Ветмедика, Инк.	Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis
US20050279889A1 (en)	2004-06-08	2005-12-22	Safe Flight Instrument Corporation	Variable wing spacecraft
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
ATE462445T1 (de)	2005-01-13	2010-04-15	Boehringer Ingelheim Vetmed	Prrs-impfstoffe
MX2007012786A (es)	2005-04-13	2008-01-11	Merial Ltd	Ensayo para produccion de circovirus porcino.
DK2371383T3 (da) *	2005-12-29	2015-11-30	Boehringer Ingelheim Vetmed	Anvendelse af en PCV2-immunogen sammensætning til mindskning af kliniske symptomer i grise
US8377070B2 (en) *	2007-05-17	2013-02-19	Michael T. Gauthier	Compressor distractor tool
US8214576B2 (en)	2009-03-03	2012-07-03	Vmware, Inc.	Zero copy transport for target based storage virtual appliances

1997
- 1997-12-05 FR FR9715396A patent/FR2772047B1/fr not_active Expired - Lifetime
1998
- 1998-12-04 PT PT101845568T patent/PT2316925E/pt unknown
- 1998-12-04 PT PT81549123T patent/PT2000535E/pt unknown
- 1998-12-04 ES ES10184626.9T patent/ES2548146T3/es not_active Expired - Lifetime
- 1998-12-04 AT AT98958957T patent/ATE412664T1/de active
- 1998-12-04 EP EP08154913.1A patent/EP1992696B1/fr not_active Expired - Lifetime
- 1998-12-04 EP EP10184626.9A patent/EP2330188B1/fr not_active Expired - Lifetime
- 1998-12-04 DK DK08154913.1T patent/DK1992696T3/da active
- 1998-12-04 PT PT101846269T patent/PT2330188E/pt unknown
- 1998-12-04 DK DK08154912.3T patent/DK2000535T3/da active
- 1998-12-04 PT PT81549131T patent/PT1992696E/pt unknown
- 1998-12-04 ES ES08154913.1T patent/ES2458309T3/es not_active Expired - Lifetime
- 1998-12-04 DK DK98958957.7T patent/DK1036180T4/da active
- 1998-12-04 PT PT98958957T patent/PT1036180E/pt unknown
- 1998-12-04 WO PCT/FR1998/002634 patent/WO1999029871A2/fr not_active Ceased
- 1998-12-04 EP EP15172572.8A patent/EP3002331A1/fr not_active Withdrawn
- 1998-12-04 AU AU14916/99A patent/AU1491699A/en not_active Abandoned
- 1998-12-04 DK DK10184626.9T patent/DK2330188T3/da active
- 1998-12-04 ES ES98958957T patent/ES2317679T5/es not_active Expired - Lifetime
- 1998-12-04 EP EP08154912.3A patent/EP2000535B1/fr not_active Expired - Lifetime
- 1998-12-04 DK DK10184556.8T patent/DK2316925T3/da active
- 1998-12-04 DE DE69840174T patent/DE69840174D1/de not_active Expired - Lifetime
- 1998-12-04 ES ES10184556.8T patent/ES2548145T3/es not_active Expired - Lifetime
- 1998-12-04 ES ES08154912.3T patent/ES2456959T3/es not_active Expired - Lifetime
- 1998-12-04 EP EP10184556.8A patent/EP2316925B1/fr not_active Expired - Lifetime
- 1998-12-04 EP EP98958957A patent/EP1036180B2/fr not_active Expired - Lifetime
2000
- 2000-02-28 US US09/514,245 patent/US6703023B1/en not_active Expired - Lifetime
2003
- 2003-04-09 US US10/409,613 patent/US20040076635A1/en not_active Abandoned
- 2003-05-21 US US10/442,180 patent/US20040091502A1/en not_active Abandoned
- 2003-08-08 US US10/637,011 patent/US7223594B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,264 patent/US7179472B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,266 patent/US7148015B2/en not_active Expired - Lifetime
2004
- 2004-02-11 US US10/775,337 patent/US20050008651A1/en not_active Abandoned
2005
- 2005-07-08 US US11/176,667 patent/US7244433B2/en not_active Expired - Lifetime
- 2005-10-31 US US11/262,514 patent/US7261898B2/en not_active Expired - Lifetime
2006
- 2006-07-17 US US11/487,589 patent/US7407803B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,885 patent/US7297537B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,926 patent/US7405075B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,306 patent/US7425444B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,302 patent/US7390494B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,237 patent/US7722883B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,291 patent/US7740865B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,305 patent/US7323330B2/en not_active Expired - Fee Related
2007
- 2007-11-01 US US11/979,296 patent/US7740866B2/en not_active Expired - Fee Related
- 2007-12-20 US US12/003,188 patent/US7741026B2/en not_active Expired - Fee Related
- 2007-12-28 US US12/003,558 patent/US7604808B2/en not_active Expired - Fee Related
2008
- 2008-07-03 US US12/216,410 patent/US7758865B2/en not_active Expired - Fee Related
- 2008-07-28 US US12/219,774 patent/US8715690B2/en not_active Expired - Fee Related
2009
- 2009-09-17 US US12/561,881 patent/US20100172924A1/en not_active Abandoned
- 2009-09-17 US US12/561,829 patent/US20100166791A1/en not_active Abandoned
- 2009-09-17 US US12/561,946 patent/US20100226934A1/en not_active Abandoned
- 2009-10-19 US US12/588,526 patent/US20110135677A1/en not_active Abandoned
- 2009-10-19 US US12/588,525 patent/US20110033489A1/en not_active Abandoned
- 2009-11-13 US US12/618,485 patent/US7951907B2/en not_active Expired - Fee Related
- 2009-12-11 US US12/636,180 patent/US20100215690A1/en not_active Abandoned
2010
- 2010-01-08 US US12/684,506 patent/US20100203072A1/en not_active Abandoned
- 2010-01-11 US US12/685,243 patent/US20100221276A1/en not_active Abandoned
- 2010-03-05 US US12/718,153 patent/US20100189732A1/en not_active Abandoned
- 2010-03-05 US US12/718,158 patent/US20100189733A1/en not_active Abandoned
- 2010-03-05 US US12/718,214 patent/US20100189743A1/en not_active Abandoned
- 2010-03-05 US US12/718,197 patent/US8124723B2/en not_active Expired - Fee Related
- 2010-03-05 US US12/718,183 patent/US20100189735A1/en not_active Abandoned
- 2010-03-05 US US12/718,168 patent/US20100189734A1/en not_active Abandoned
- 2010-04-28 US US12/768,897 patent/US20100209453A1/en not_active Abandoned
2011
- 2011-09-06 US US13/226,013 patent/US8415525B2/en not_active Expired - Fee Related
- 2011-10-20 US US13/277,582 patent/US8916353B2/en not_active Expired - Fee Related
2014
- 2014-04-11 CY CY20141100270T patent/CY1115405T1/el unknown
- 2014-05-05 CY CY20141100318T patent/CY1115424T1/el unknown
- 2014-08-14 BE BE2014C050C patent/BE2014C050I2/fr unknown
- 2014-08-14 BE BE2014C049C patent/BE2014C049I2/fr unknown
- 2014-08-14 NL NL300685C patent/NL300685I2/nl unknown
- 2014-08-14 NL NL300686C patent/NL300686I2/nl unknown
- 2014-08-18 LU LU92523C patent/LU92523I2/xx unknown
- 2014-08-18 LU LU92524C patent/LU92524I2/xx unknown
- 2014-08-19 CY CY2014036C patent/CY2014036I1/el unknown
- 2014-08-19 FR FR14C0062C patent/FR14C0062I2/fr active Active
- 2014-08-19 FR FR14C0061C patent/FR14C0061I2/fr active Active
- 2014-08-19 CY CY2014035C patent/CY2014035I2/el unknown
- 2014-11-14 US US14/541,516 patent/US9700613B2/en not_active Expired - Fee Related
- 2014-11-14 US US14/541,268 patent/US9717784B2/en not_active Expired - Fee Related
2015
- 2015-09-30 CY CY20151100872T patent/CY1116761T1/el unknown
- 2015-10-09 CY CY20151100916T patent/CY1116837T1/el unknown
2016
- 2016-09-07 HK HK16110634.3A patent/HK1222415A1/zh unknown
2017
- 2017-07-28 US US15/662,772 patent/US10052375B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20040091502A1 (en)	2004-05-13
WO1999029871A3 (fr)	1999-08-19
EP1036180A2 (fr)	2000-09-20
CY1115424T1 (el)	2016-04-13
US20120034630A1 (en)	2012-02-09
US7740866B2 (en)	2010-06-22
US20100189735A1 (en)	2010-07-29
US7390494B2 (en)	2008-06-24
EP2000535B1 (fr)	2014-01-22
US20070041989A1 (en)	2007-02-22
WO1999029871A2 (fr)	1999-06-17
EP2316925A1 (fr)	2011-05-04
DK1992696T3 (da)	2014-05-19
US20100189734A1 (en)	2010-07-29
ES2458309T3 (es)	2014-04-30
US20090092627A1 (en)	2009-04-09
US7297537B2 (en)	2007-11-20
HK1158254A1 (en)	2012-07-13
US20080233147A1 (en)	2008-09-25
DK2316925T3 (da)	2015-10-12
US7740865B2 (en)	2010-06-22
US20040265848A1 (en)	2004-12-30
US20150175668A1 (en)	2015-06-25
US20050084497A1 (en)	2005-04-21
US20100189733A1 (en)	2010-07-29
US20110033489A1 (en)	2011-02-10
DK2000535T3 (da)	2014-04-22
FR14C0061I2 (fr)	2016-06-24
US20070048780A1 (en)	2007-03-01
US20070059324A1 (en)	2007-03-15
US7405075B2 (en)	2008-07-29
US20090123490A1 (en)	2009-05-14
US20100221276A1 (en)	2010-09-02
US20070065925A1 (en)	2007-03-22
NL300686I2 (nl)	2022-03-22
EP3002331A1 (fr)	2016-04-06
US9717784B2 (en)	2017-08-01
US20100226934A1 (en)	2010-09-09
US20070041990A1 (en)	2007-02-22
PT2316925E (pt)	2015-10-23
US8916353B2 (en)	2014-12-23
US7722883B2 (en)	2010-05-25
US7223594B2 (en)	2007-05-29
HK1125676A1 (en)	2009-08-14
ES2548146T3 (es)	2015-10-14
PT2330188E (pt)	2015-10-23
ES2317679T3 (es)	2009-04-16
BE2014C050I2 (en)	2018-07-04
PT2000535E (pt)	2014-05-02
EP2316925B1 (fr)	2015-07-08
AU1491699A (en)	1999-06-28
US20100215690A1 (en)	2010-08-26
US20070110767A1 (en)	2007-05-17
DE69840174D1 (de)	2008-12-11
EP1992696B1 (fr)	2014-02-19
ES2317679T5 (es)	2012-02-24
DK1036180T3 (da)	2009-03-09
EP2330188B1 (fr)	2015-07-15
FR14C0061I1 (da)	2014-10-10
HK1158694A1 (en)	2012-07-20
US7407803B2 (en)	2008-08-05
US20100189736A1 (en)	2010-07-29
US20100189743A1 (en)	2010-07-29
CY2014035I1 (el)	2016-04-13
US20100166791A1 (en)	2010-07-01
US20050008651A1 (en)	2005-01-13
CY2014036I2 (el)	2016-04-13
LU92523I2 (fr)	2014-10-20
US7604808B2 (en)	2009-10-20
EP1036180B2 (fr)	2011-11-02
EP1036180B1 (fr)	2008-10-29
US20070059325A1 (en)	2007-03-15
ES2456959T3 (es)	2014-04-24
US8415525B2 (en)	2013-04-09
US7261898B2 (en)	2007-08-28
CY1115405T1 (el)	2017-01-04
EP2330188A1 (fr)	2011-06-08
FR2772047A1 (fr)	1999-06-11
FR2772047B1 (fr)	2004-04-09
CY1116761T1 (el)	2017-03-15
US20100221283A1 (en)	2010-09-02
FR14C0062I2 (fr)	2016-06-24
NL300685I2 (nl)	2022-03-22
US7148015B2 (en)	2006-12-12
CY1116837T1 (el)	2017-03-15
US20070253971A1 (en)	2007-11-01
US20040076635A1 (en)	2004-04-22
US7323330B2 (en)	2008-01-29
ATE412664T1 (de)	2008-11-15
US7741026B2 (en)	2010-06-22
US7244433B2 (en)	2007-07-17
EP2000535A1 (fr)	2008-12-10
US20060222663A1 (en)	2006-10-05
US20110135677A1 (en)	2011-06-09
US8715690B2 (en)	2014-05-06
US20100074919A1 (en)	2010-03-25
EP1992696A1 (fr)	2008-11-19
CY2014035I2 (el)	2016-04-13
ES2548145T3 (es)	2015-10-14
HK1222415A1 (zh)	2017-06-30
FR14C0062I1 (da)	2014-10-10
US10052375B2 (en)	2018-08-21
US20180000927A1 (en)	2018-01-04
LU92524I2 (fr)	2014-10-20
US7951907B2 (en)	2011-05-31
HK1126522A1 (en)	2009-09-04
US20090162918A1 (en)	2009-06-25
BE2014C049I2 (en)	2018-07-04
US7179472B2 (en)	2007-02-20
US20040161410A1 (en)	2004-08-19
US20100172924A1 (en)	2010-07-08
US7758865B2 (en)	2010-07-20
US20100203072A1 (en)	2010-08-12
US20150182616A1 (en)	2015-07-02
US6703023B1 (en)	2004-03-09
US20060083756A1 (en)	2006-04-20
US9700613B2 (en)	2017-07-11
CY2014036I1 (el)	2016-04-13
PT1036180E (pt)	2009-02-10
US8124723B2 (en)	2012-02-28
PT1992696E (pt)	2014-05-27
US20100209453A1 (en)	2010-08-19
DK1036180T4 (da)	2012-01-23
US7425444B2 (en)	2008-09-16
US20120005768A1 (en)	2012-01-05
NL300685I1 (da)	2014-08-27
NL300686I1 (da)	2014-08-27
US20100189732A1 (en)	2010-07-29

Publication	Publication Date	Title
DK2330188T3 (da)	2015-10-19	Circovirus-sekvenser i sammenhæng med pattegrisafmagringssygdom (MAP)
JP2001511347A5 (da)	2006-01-05
JP2004508043A5 (da)	2008-09-11
CA2383424A1 (en)	2001-03-01	Novel b7-4 molecules and uses therefor
JP2001514879A5 (da)	2006-02-16
RU2003106809A (ru)	2004-08-10	Гены гомологичных иммунодоминантных белков ehrlichia canis в 28-килодальтон и их применение
CA2421588A1 (en)	2002-03-14	Tnf receptor-like molecules and uses thereof
CA2343979A1 (en)	2000-03-30	Human interleukin-b50, therapeutic uses
Jasmer et al.	1996	Haemonchus contortus GA1 antigens: related, phospholipase C-sensitive, apical gut membrane proteins encoded as a polyprotein and released from the nematode during infection.
CA2411949A1 (en)	2001-12-20	Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
JP2000508881A (ja)	2000-07-18	免疫グロブリン遺伝子の再編成されたゲノム可変領域のｐｃｒ増幅
JP2005535287A5 (da)	2006-03-30
JP2003527073A5 (da)	2007-01-11
JP2005528080A5 (da)	2006-01-05
Vanderheijden et al.	1993	Expression of the bovine viral diarrhoea virus Osloss p80 protein: its use as ELISA antigen for cattle serum antibody detection
JP2002523094A5 (da)	2006-10-12
Lankinen et al.	1989	The unique N-terminal domain of the large subunit of herpes simplex virus ribonucleotide reductase is preferentially sensitive to proteolysis
JPH03501205A (ja)	1991-03-22	ペプチジル‐グリシンアルファ‐アミド化モノオキシゲナーゼ（ＰＡＭ）をコードするｃＤＮＡ
JP2008509659A5 (da)	2008-09-04
JPH04144686A (ja)	1992-05-19	構造蛋白質遺伝子、組換えベクター、それにより形質転換された大腸菌、ポリペプチドおよびポリペプチドの製造方法
JP2005506833A5 (da)	2006-01-05
ES2029938A6 (es)	1992-10-01	Metodo para la obtencion de peptidos y proteinas recombinantes de fusion de la subunidad vp2 de parvovirus canino cpv, y su empleo en metodos de diagnostico y en la fdormulacion de vacunas.
JP2004514448A5 (da)	2005-04-07
JPH04218388A (ja)	1992-08-07	ソマトトロピン結合蛋白質を特異的に認識する抗体
WO2000068249B1 (en)	2002-01-17	Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor